Karyopharm Therapeutics KPTI reported its Q1 earnings results on Thursday, May 4, 2023 at 07:45 AM.
Here's what investors need to know about the announcement.
Earnings
Karyopharm Therapeutics beat estimated earnings by 18.92%, reporting an EPS of $-0.3 versus an estimate of $-0.37.
Revenue was down $8.97 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 1.91% drop in the share price the next day.
Here's a look at Karyopharm Therapeutics's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | -0.35 | -0.57 | -0.63 | -0.63 |
EPS Actual | -0.43 | -0.45 | -0.62 | -0.53 |
Revenue Estimate | 35.12M | 34.56M | 35.59M | 34.17M |
Revenue Actual | 33.58M | 36.15M | 39.68M | 47.67M |
To track all earnings releases for Karyopharm Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.